http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037045-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30e7e2ab820f4e6084eb0a83c7ace9e0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-113
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-113
filingDate 1999-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a697d38c2727b93c01cc0f37e7502a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bab39a293c84a37b22bee1fa90885d19
publicationDate 2000-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0037045-A3
titleOfInvention Stabilized water-in-oil-in-water antigen delivery system
abstract A water-in-oil-in-water (W/O/W) emulsion to be used in an antigen delivery system to induce rapid and long-lasting immunity among populations of livestock, birds, and fish. The external aqueous phase of the W/O/W emulsion contains a thixotropic inorganic salt, such as aluminum hydroxide or alum. The presence of the inorganic salt helps to elicit both a Th1 and a Th2 response from the subject's immune system, and the thixotropic properties of the salt stabilize the water-in-oil-in-water emulsion, thereby providing a longer vaccine shelf life. The antigen dose to be delivered to the subject may be contained in entirely in the internal aqueous phase. Alternatively, a first portion of the total antigen dose may be included in the internal aqueous phase and a second portion is included in the external aqueous phase. The incorporation of a portion of the antigen in the external aqueous phase triggers a more uniform immune response across a vaccinated population. The W/O/W based vaccines can be administered either by injection or orally.
priorityDate 1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3531565-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1152607-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3399263-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0827028-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448467028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 23.